Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Syndax Pharmaceuticals, Inc. (SNDX) had Debt to Capital Ratio of 0.84 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$68.48M |
|
$-68.01M |
|
$2.71M |
|
$65.78M |
|
$131.03M |
|
$-62.55M |
|
$-5.47M |
|
$-68.01M |
|
$-68.01M |
|
$-68.01M |
|
$-68.01M |
|
$-68.01M |
|
$-68.01M |
|
$-62.55M |
|
$-64.08M |
|
86.63M |
|
86.63M |
|
$-0.78 |
|
$-0.78 |
|
| Balance Sheet Financials | |
$528.08M |
|
$0.18M |
|
$1.62M |
|
$529.71M |
|
$120.12M |
|
$343.91M |
|
$344.96M |
|
$465.08M |
|
$64.63M |
|
$64.63M |
|
$64.63M |
|
87.41M |
|
| Cash Flow Statement Financials | |
$-322.98M |
|
$290.04M |
|
$13.68M |
|
$154.30M |
|
$135.03M |
|
$-19.27M |
|
$47.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.40 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.84 |
5.32 |
|
96.05% |
|
-91.34% |
|
-91.34% |
|
-- |
|
-99.32% |
|
-99.32% |
|
$-323.17M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
0.08 |
|
1.00 |
|
89.56 |
|
-105.24% |
|
-105.24% |
|
-12.84% |
|
-16.65% |
|
$0.74 |
|
$-3.73 |
|
$-3.73 |
|